Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$883M |
| 2 |
Boeing
BA
|
+$345M |
| 3 |
Salesforce
CRM
|
+$344M |
| 4 |
DexCom
DXCM
|
+$301M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$253M |
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$585M |
| 3 |
Home Depot
HD
|
+$264M |
| 4 |
Chubb
CB
|
+$263M |
| 5 |
PepsiCo
PEP
|
+$263M |
Sector Composition
| 1 | Technology | 16.53% |
| 2 | Healthcare | 15.07% |
| 3 | Financials | 14.94% |
| 4 | Industrials | 11.6% |
| 5 | Consumer Discretionary | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRVB
2151
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $4.47M | ﹤0.01% |
+423,295
| New | +$4.47M |
|
|
MYOV
2152
DELISTED
Myovant Sciences Ltd.
MYOV
| $4.47M | ﹤0.01% |
165,659
+152,094
| +1,121% | +$4.1M |
|
2153
ZimVie
ZIMV
$533M
| $4.46M | ﹤0.01% |
477,619
+329,384
| +222% | +$3.08M |
|
2154
American Public Education
APEI
$640M
| $4.45M | ﹤0.01% |
362,391
-235,059
| -39% | -$2.89M |
|
|
LITT
2155
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
| $4.45M | ﹤0.01% |
446,940
+20,000
| +5% | +$199K |
|
2156
Cato Corp
CATO
$90M
| $4.44M | ﹤0.01% |
475,771
+445,852
| +1,490% | +$4.16M |
|
2157
Magnachip Semiconductor
MX
$114M
| $4.42M | ﹤0.01% |
470,885
-286,286
| -38% | -$2.69M |
|
|
MCHB
2158
Mechanics Bancorp Class A Common Stock
MCHB
$2.92B
| $4.42M | ﹤0.01% |
160,304
-135,482
| -46% | -$3.74M |
|
|
VRE
2159
Veris Residential
VRE
$1.44B
| $4.41M | ﹤0.01% |
277,061
+244,068
| +740% | +$3.89M |
|
|
DESP
2160
DELISTED
Despegar.com
DESP
| $4.41M | ﹤0.01% |
859,224
+570,243
| +197% | +$2.93M |
|
|
USCT
2161
DELISTED
Roth CH Acquisition Co. Class A Ordinary Shares
USCT
| $4.41M | ﹤0.01% |
427,819
| – | – |
|
2162
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $4.39M | ﹤0.01% |
54,099
+24,399
| +82% | +$1.98M |
|
2163
Allison Transmission
ALSN
$7.34B
| $4.39M | ﹤0.01% |
105,482
+42,466
| +67% | +$1.77M |
|
|
APEN
2164
DELISTED
Apollo Endosurgery, Inc.
APEN
| $4.39M | ﹤0.01% |
439,913
+388,982
| +764% | +$3.88M |
|
2165
iShares MSCI Mexico ETF
EWW
$1.94B
| $4.38M | ﹤0.01% |
88,546
-134,091
| -60% | -$6.63M |
|
2166
Southland Holdings
SLND
$233M
| $4.37M | ﹤0.01% |
427,940
-1,121
| -0.3% | -$11.5K |
|
2167
Powell Industries
POWL
$3.65B
| $4.37M | ﹤0.01% |
124,105
+74,955
| +153% | +$2.64M |
|
|
AVDL
2168
Avadel Pharmaceuticals
AVDL
$1.47B
| $4.36M | ﹤0.01% |
+609,336
| New | +$4.36M |
|
2169
Ionis Pharmaceuticals
IONS
$9.74B
| $4.36M | ﹤0.01% |
115,506
+96,577
| +510% | +$3.65M |
|
2170
Bumble
BMBL
$729M
| $4.36M | ﹤0.01% |
207,163
+99,534
| +92% | +$2.1M |
|
2171
Liquidity Services
LQDT
$862M
| $4.34M | ﹤0.01% |
+308,426
| New | +$4.34M |
|
2172
Shopify
SHOP
$192B
| $4.33M | ﹤0.01% |
124,803
-118,100
| -49% | -$4.1M |
|
2173
AbCellera Biologics
ABCL
$1.3B
| $4.33M | ﹤0.01% |
427,548
-441,756
| -51% | -$4.47M |
|
2174
Insteel Industries
IIIN
$750M
| $4.32M | ﹤0.01% |
156,956
+47,128
| +43% | +$1.3M |
|
2175
Arbutus Biopharma
ABUS
$868M
| $4.32M | ﹤0.01% |
1,852,715
-1,657,473
| -47% | -$3.86M |
|